The Efficacy of Plastic Stent Anchoring to Reduce Migration of Metal Stent
The Efficacy of a Fully Covered Self-expandable Metal Stent Anchored by a Plastic Stent for Anti-migration in the Management of Malignant Biliary Strictures: a Prospective Randomized Controlled Study
1 other identifier
interventional
70
1 country
1
Brief Summary
The aim of this study is to demonstrate that the group with an additional plastic stent to anchor the fully covered self expandable metal stent (FCSEMS) in patients with malignant biliary stricture has less stent migration than the group with FCSEMS only. The primary outcome is stent migration for 6 months. The secondary outcomes are stent related adverse events, stent patency, and overall survival.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 1, 2018
CompletedFirst Posted
Study publicly available on registry
February 20, 2018
CompletedStudy Start
First participant enrolled
February 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2019
CompletedNovember 21, 2019
November 1, 2019
1.7 years
February 1, 2018
November 20, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Stent migration rate
Stent migration is classified as proximal or distal migration. Proximal stent migration is defined as any migration of the FCSEMS(Fully covered self expandable metal stent) into the bile duct, preventing its easy removal. Distal stent migration is defined in three ways. The first is when the stent is completely distally migrated without being lodged into the duodenum. The second is when the stent is lodged in the distal bile duct below the stricture. The third case is when the stent is migrated to the distal portion of the stricture and is lodged in the duodenum opposite the papilla
6 months after randomization
Secondary Outcomes (3)
Stent-related adverse events
6 months after randomization
Duration of stent patency
6 months after randomization
Overall survival
6 months after randomization
Study Arms (2)
FCSEMS + Plastic
EXPERIMENTALInsert a fully covered self expandable metal stent (FCSEMS) for malignant biliary stricture and insert an additional plastic stent to anchor the metal stent. (Plastic stent anchoring)
FCSEMS
ACTIVE COMPARATORInsert only a fully covered self expandable metal stent (FCSEMS) without a plastic stent for malignant biliary stricture.
Interventions
Insert an additional plastic stent to anchor the fully covered self expandable metal stent.
Insert a fully covered self expandable metal stent (FCSEMS) for malignant biliary stricture
Eligibility Criteria
You may qualify if:
- Malignant biliary stricture requiring biliary drainage through endoscopic procedure
You may not qualify if:
- Previous history of metal stent placement for malignant biliary stricture
- Hilar cholangiocarcinoma
- Malignant biliary stricture of intrahepatic duct
- A recurrence after surgery due to malignant biliary stricture
- Life expectancy less than 3 months
- Pregnancy
- If endoscopy is not possible based on the judgement of the researcher
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Hospital
Seoul, 03080, South Korea
Related Publications (1)
Paik WH, Woo SM, Chun JW, Song BJ, Lee WJ, Ahn DW, Lee YS, Choi YH, Ryu JK, Kim YT, Lee SH. Efficacy of an internal anchoring plastic stent to prevent migration of a fully covered metal stent in malignant distal biliary strictures: a randomized controlled study. Endoscopy. 2021 Jun;53(6):578-585. doi: 10.1055/a-1256-0571. Epub 2020 Oct 8.
PMID: 32886935DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Sang Hyub Lee, MD, PhD
Seoul National University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 1, 2018
First Posted
February 20, 2018
Study Start
February 26, 2018
Primary Completion
October 31, 2019
Study Completion
October 31, 2019
Last Updated
November 21, 2019
Record last verified: 2019-11